Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Teriparatide for Joint Erosions in Rheumatoid Arthritis: The TERA Trial

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2014 by Brigham and Women's Hospital
Sponsor:
Collaborator:
Eli Lilly and Company
Information provided by (Responsible Party):
Daniel H. Solomon, M.D.,MPH, Brigham and Women's Hospital
ClinicalTrials.gov Identifier:
NCT01400516
First received: July 21, 2011
Last updated: September 2, 2014
Last verified: September 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2015
  Estimated Primary Completion Date: August 2015 (Final data collection date for primary outcome measure)